Stanford Webinar - A Conversation on the Future of Translational Medicine
View the details of our Drug Development: From Discovery to Commercialization Graduate Certificate:🎓 https://online.stanford.edu/programs/drug-development-discovery-commercialization-graduate-certificate
What does it take to move a discovery from the lab into the clinic, and who's equipped to lead that work? Translational medicine is the discipline sitting at that critical crossroads — bridging groundbreaking research and real-world patient care.
Listen to and watch faculty leaders of Stanford's Master of Science in Translational Research and Applied Medicine (M-TRAM) program, Dean Felsher, MD, PhD, and Joanna Liliental, PhD, have a lively conversation and Q&A session.
In this webinar, they discuss the real challenges facing translational research today, the opportunities emerging at the intersection of science and industry, and what it takes to train the next generation of innovators ready to turn discovery into impact.
Speakers:
Dean Felsher, MD, PhD, is a Professor of Medicine-Oncology at Stanford University School of Medicine and Director of the Translational Research and Applied Medicine (TRAM) Program, which he has led since 2011. His laboratory investigates how oncogenes initiate and sustain cancer, and he has pioneered model systems showing that inactivating a single oncogene, such as MYC, can be sufficient to reverse tumor growth — a concept known as "oncogene addiction."
Joanna Liliental, PhD, is Executive Director of Stanford's Master's in Translational Research and Applied Medicine (M-TRAM) program, Director of the Translational Applications Service Center (TASC), and Associate Director of the Translational Research and Applied Medicine (TRAM) Program. Since 2011, she has worked alongside Dean Felsher, mentoring researchers as they move scientific findings from the lab into clinical application, including biomarker research for early cancer detection.
The graduate course TRAM223B Drug Development and Clinical Trials will be available for the winter quarter. Enrollment begins October 19. Learn course details:
🎓 https://online.stanford.edu/courses/tram223b-drug-development-and-clinical-trials Receive SMS online on sms24.me
TubeReader video aggregator is a website that collects and organizes online videos from the YouTube source. Video aggregation is done for different purposes, and TubeReader take different approaches to achieve their purpose.
Our try to collect videos of high quality or interest for visitors to view; the collection may be made by editors or may be based on community votes.
Another method is to base the collection on those videos most viewed, either at the aggregator site or at various popular video hosting sites.
TubeReader site exists to allow users to collect their own sets of videos, for personal use as well as for browsing and viewing by others; TubeReader can develop online communities around video sharing.
Our site allow users to create a personalized video playlist, for personal use as well as for browsing and viewing by others.
@YouTubeReaderBot allows you to subscribe to Youtube channels.
By using @YouTubeReaderBot Bot you agree with YouTube Terms of Service.
Use the @YouTubeReaderBot telegram bot to be the first to be notified when new videos are released on your favorite channels.
Look for new videos or channels and share them with your friends.
You can start using our bot from this video, subscribe now to Stanford Webinar - A Conversation on the Future of Translational Medicine
What is YouTube?
YouTube is a free video sharing website that makes it easy to watch online videos. You can even create and upload your own videos to share with others. Originally created in 2005, YouTube is now one of the most popular sites on the Web, with visitors watching around 6 billion hours of video every month.
